Genital Herpes
📧 Sign up to get email alerts when something new happens for Genital Herpes.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-08-16FDA Approved: ACYCLOVIR — Original Application (Carlsbad Technology, Inc.)
FDA approves a generic acyclovir product under an Original Application (ANDA) from Carlsbad Technology, Inc.
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide [Phase 2]
Phase 2 trial assessing PC-515 as a vaginal microbicide reports safety, acceptability, and preliminary effectiveness data.
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and Shedding [NA]
A completed clinical trial evaluated valacyclovir for reducing recurrence and shedding of HSV-2, including HIV-infected participants, with r…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)
A completed clinical trial update on the use of valaciclovir (Valtrex) for suppression prophylaxis in genital herpes.
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2 [Phase 4]
Phase 4 randomized trial comparing high-dose valacyclovir with once-daily valacyclovir in people with HSV-2 genital herpes has completed. Th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation [Phase 4]
A Phase 4 randomized trial evaluated whether suppressive treatment with acyclovir reduces rapid HSV-2 reactivation in individuals with genit…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease [Phase 3]
Phase 3 trial assessing the safety of a herpes simplex vaccine candidate (gD2t) with MPL and its efficacy in preventing genital herpes.
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food [Phase 1]
Phase 1 study evaluating the safety, pharmacokinetics, and the effect of food on single doses of ASP2151 in healthy male subjects; the trial…
-
FDA approval · 2016-04-08FDA Approved: ACYCLOVIR — Supplemental Application (Quinn Pharmaceuticals)
FDA approved a supplemental application for acyclovir submitted by Quinn Pharmaceuticals, indicating regulatory approval of a supplement for…
-
FDA approval · 2016-03-24FDA Approved: FAMCICLOVIR — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for famciclovir from Aurobindo Pharma Limited (ANDA 091114), indicating approval of a supplemental s…
-
FDA approval · 2016-03-04FDA Approved: FAMCICLOVIR — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Apotex Corp. to market a generic version of famciclovir.
-
FDA approval · 2016-02-29FDA Approved: ACYCLOVIR — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc. for an original application of acyclovir as a generic product, expanding generic options for acy…
-
FDA approval · 2015-10-26FDA Approved: VALACYCLOVIR — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for Valacyclovir submitted by Quallent Pharmaceuticals Health LLC. The action confirms regulator…
-
FDA approval · 2015-08-20FDA Approved: ACYCLOVIR — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for acyclovir from Amneal Pharmaceuticals LLC, supporting a generic formulation of acyclovir.
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes [Phase 3]
Phase 3 trial comparing oral famciclovir 125 mg to aciclovir 200 mg in active recurrent genital herpes completed with results posted in 2015…
-
FDA approval · 2015-04-08FDA Approved: VALACYCLOVIR — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved Quallent Pharmaceuticals Health LLC's original ANDA for Valacyclovir, providing a generic option for treating common herpes inf…
-
FDA approval · 2014-10-24FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for Valacyclovir hydrochloride from Aurobindo Pharma Limited, granting approval of a generic product…
-
CLINICAL_TRIALS trial_result · 2014-10-08Clinical Trial Update: Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2 [Phase 4]
Phase 4 randomized trial comparing high-dose acyclovir suppressive therapy to once-daily valacyclovir in adults with genital herpes; results…
-
FDA approval · 2014-09-10FDA Approved: FAMCICLOVIR — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved a generic version of famciclovir under an original ANDA from Camber Pharmaceuticals, Inc.
-
FDA approval · 2014-08-19FDA Approved: ACYCLOVIR — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved the original (ANDA) application for a generic acyclovir product from Zydus Pharmaceuticals (USA) Inc., enabling a generic versi…
-
CLINICAL_TRIALS other · 2014-08-05Clinical Trial Update: A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes [Phase 2]
A Phase 2 clinical trial evaluating polyethylene glycol (PEG) for genital herpes has been terminated; the update notes the study's focus on …
-
FDA approval · 2014-04-01FDA Approved: ACYCLOVIR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for acyclovir from Teva Pharmaceuticals USA, Inc., updating the drug’s approval details. The supplem…
-
FDA approval · 2014-03-06FDA Approved: ACYCLOVIR — Original Application (Nivagen Pharmaceuticals, Inc.)
FDA approved the original ANDA for acyclovir from Nivagen Pharmaceuticals, authorizing a generic version of the antiviral for several herpes…
-
FDA approval · 2013-11-15FDA Approved: ACYCLOVIR — Original Application (Modavar Pharmaceuticals LLC)
FDA approved Modavar Pharmaceuticals LLC's original ANDA for acyclovir, enabling a generic version of the antiviral for common herpes simple…
-
CLINICAL_TRIALS trial_result · 2013-08-23Clinical Trial Update: VivaGel™ in Healthy Young Women [Phase 1]
A Phase 1 clinical trial of VivaGel in healthy young women to assess safety/tolerability for preventing HSV-2 infection has completed.